Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + FUNIL in Advanced Renal Cell Carcinoma
NCT00277017Phase 2Completed
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Sep 2000
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thalidomide in renal cell carcinoma (RCC), sponsored by New Mexico Cancer Research Alliance. Primary endpoint: Evaluation of FUNIL regimen with Thalidomide. Started Sep 2000; status: completed.
02
Drugs
thalidomide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00277017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277017.